Skip to content

Helping Adults Perform Transvaginal Exams Via Coaching at Home

HATCH (Helping Adults Perform Transvaginal Exams Via Coaching at Home) Study: Protocol for Training Ultrasound Technologists to Conduct At-home, Remote Transvaginal Ultrasounds

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05282524
Acronym
HATCH
Enrollment
67
Registered
2022-03-16
Start date
2022-03-23
Completion date
2023-02-07
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women's Health

Brief summary

To train ultrasound technologists (equivalently called sonographers) in remote ultrasound guidance. To capture imaging of the gynecologic organs visible on home ultrasound and pertinent to clinical care, specifically the ovaries and uterus. To train the independent readers, both obstetricians & gynecologists (OB/GYNs) and reproductive endocrinologists (REIs), who will evaluate home ultrasound images over time in subsequent clinical trials.

Interventions

DEVICETransvaginal ultrasound performed by a woman herself (with remote healthcare professional supervision)

Imaging performed by woman on herself with remote healthcare professional (HCP) supervision. The ultrasound device used is cleared for HCP-supervised use in environments where healthcare is provided by trained HCPs. No changes to the design or manufacture have been made for this study.

Sponsors

Turtle Health, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women aged 18 and over who have not gone through menopause (defined as no menstruation for at least 12 months, not explained by other causes) * Women with body mass index (BMI) up to 40 * Women who speak English, assessed through screening questions * Women with at least a high school degree or equivalent (e.g., General Educational Development (GED) or similar) * Women located in Massachusetts * Women who are able to safely receive delivery of the ultrasound scanner * Women between cycle days 3 and 10 at the time of testing as a mitigation against potential inadvertent early fetal exposure; or intrauterine device (IUD) users who do not have a menses * Women who have all three primary gynecological organs: left ovary, right ovary, and uterus

Exclusion criteria

* Women with BMI over 40 * Women who do not speak English natively or fluently * Women who have recently given birth, and have had fewer than 3 postpartum menstrual cycles * Women who have recently had a stillbirth or abortion more than 20 weeks (subject to the 3 postpartum menstrual cycles above). Miscarriages or abortions less than 20 weeks are subject to two wait cycles * Women who are currently pregnant or may be pregnant * Women who have had a hysterectomy or oophorectomy * Women who have changed birth control within the current menstrual cycle. (One 'washout' cycle is required) * Women with cancer of any pelvic organ * Women who are not able to schedule an exam while meeting the requirements above prior to the end of the trial. For example, women who change birth control within the last cycle of the trial (and would require a 'washout cycle' that would delay trial close) or who are unable to schedule within the last few weeks of the trial after reasonable scheduling efforts have been made may be excluded. * Women with disabilities are excluded only if their disability precludes their ability to manipulate an ultrasound and follow technologist instructions

Design outcomes

Primary

MeasureTime frameDescription
Video quality of remote self-performed ultrasound exam1 visit (up to 1 hour)Determination of whether each organ view is 'diagnostic quality' or 'not diagnostic quality' based on American Institute of Ultrasound in Medicine (AIUM) criteria/guidelines

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026